Why Did bioAffinity Technologies (BIAF) Plunge 30.34%?

On April 3, 2025, bioAffinity Technologies, Inc. (BIAF) experienced a significant drop of 30.34% in pre-market trading, marking a notable decline in its stock price.

bioAffinity Technologies, Inc. (BIAF) has seen a decline in its earnings per share (EPS) by 31.25% from the third quarter of 2024 to the fourth quarter of 2024. Additionally, the company's revenue decreased by 6.08% during the same period. These financial metrics indicate a challenging quarter for the company, which may have contributed to the recent stock price decline.

Despite the recent decline, bioAffinity Technologies reported record revenue of $9.4 million for 2024, representing a significant increase of approximately 270% from $2.5 million in 2023. This substantial growth in revenue was driven by a 1,400% increase in certain segments of the business, highlighting the company's potential for future growth.

However, the company's financial performance for the most recent fiscal year shows a net income of $-7,940,000.00 and net margins of -91.22%, indicating that while revenue is growing, the company is still operating at a loss. This financial situation may be a concern for investors, contributing to the recent stock price volatility.